Sebastian Ens is an associate in the Corporate practice of Paul Hastings and is based in the firm’s Frankfurt office. He focuses on M&A, joint ventures and corporate restructurings as well as on corporate, commercial and contract law. Before joining Paul Hastings in October 2018, Mr. Ens worked for a major British law firm in Frankfurt for several years. Mr. Ens is fluent in German, English, French and Portuguese.
Recent Representations
(with Paul Hastings only)
- Advised Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma”; Stock Code: 600196.SH, 02196.HK), one of the leading Chinese healthcare groups, in forming a strategic alliance with Biopharmaceutical New Technologies of Germany (“BioNTech”; Nasdaq: BNTX) to develop and commercialize a vaccine that prevents COVID-19 infections using BioNTech’s mRNA vaccine candidate BNT162.
- Advised Hansol Paper Co., Ltd., the largest paper manufacturer in Korea, on the sale of its European Schades and R+S group companies to U.S-based Iconex, a market leader in low-cost paper receipt and differentiated label solutions.